Skip to main content

Research Repository

Advanced Search

Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer's disease

Hamilton, Calum A.; Matthews, Fiona E.; Allan, Louise M.; Barker, Sally; Ciafone, Joanna; Donaghy, Paul C.; Durcan, Rory; Firbank, Michael J.; Lawley, Sarah; O'Brien, John T.; Roberts, Gemma; Taylor, John Paul; Thomas, Alan J.

Authors

Calum A. Hamilton

Louise M. Allan

Sally Barker

Joanna Ciafone

Paul C. Donaghy

Rory Durcan

Michael J. Firbank

Sarah Lawley

John T. O'Brien

Gemma Roberts

John Paul Taylor

Alan J. Thomas



Abstract

Objectives: Previous research has identified that dementia with Lewy bodies (DLB) has abnormal pareidolic responses which are associated with severity of visual hallucinations (VH), and the pareidolia test accurately classifies DLB with VH. We aimed to assess whether these findings would also be evident at the earlier stage of mild cognitive impairment (MCI) with Lewy bodies (MCI-LB) in comparison to MCI due to AD (MCI-AD) and cognitively healthy comparators. Methods: One-hundred and thirty-seven subjects were assessed prospectively in a longitudinal study with a mean follow-up of 1.2 years (max = 3.7): 63 MCI-LB (22% with VH) and 40 MCI-AD according to current research diagnostic criteria, and 34 healthy comparators. The pareidolia test was administered annually as a repeated measure. Results: Probable MCI-LB had an estimated pareidolia rate 1.2–6.7 times higher than MCI-AD. Pareidolia rates were not associated with concurrent VH, but had a weak association with total score on the North East Visual Hallucinations Inventory. The pareidolia test was not an accurate classifier of either MCI-LB (Area under curve (AUC) = 0.61), or VH (AUC = 0.56). There was poor sensitivity when differentiating MCI-LB from controls (41%) or MCI-AD (27%), though specificity was better (91% and 89%, respectively). Conclusions: Whilst pareidolic responses are specifically more frequent in MCI-LB than MCI-AD, sensitivity of the pareidolia test is poorer than in DLB, with fewer patients manifesting VH at the earlier MCI stage. However, the high specificity and ease of use may make it useful in specialist clinics where imaging biomarkers are not available.

Citation

Hamilton, C. A., Matthews, F. E., Allan, L. M., Barker, S., Ciafone, J., Donaghy, P. C., Durcan, R., Firbank, M. J., Lawley, S., O'Brien, J. T., Roberts, G., Taylor, J. P., & Thomas, A. J. (2021). Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer's disease. International journal of geriatric psychiatry, 36(9), 1407-1414. https://doi.org/10.1002/gps.5546

Journal Article Type Article
Acceptance Date Mar 21, 2021
Online Publication Date Mar 27, 2021
Publication Date Sep 1, 2021
Deposit Date Mar 31, 2024
Publicly Available Date Apr 3, 2024
Journal International Journal of Geriatric Psychiatry
Print ISSN 0885-6230
Electronic ISSN 1099-1166
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 36
Issue 9
Pages 1407-1414
DOI https://doi.org/10.1002/gps.5546
Keywords Dementia with Lewy bodies; Mild cognitive impairment; Pareidolia; Visual hallucinations
Public URL https://hull-repository.worktribe.com/output/4451286

Files

Published article (383 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0

Copyright Statement
© 2021 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.




You might also like



Downloadable Citations